Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
94,076
-
Share change
-
+12,305
-
Total reported value
-
$3,685,644
-
Price per share
-
$39.04
-
Number of holders
-
14
-
Value change
-
+$477,760
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG) as of Q3 2025
As of 30 Sep 2025,
ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,076 shares.
The largest 10 holders included
UBS Group AG, XY Capital Ltd, Point72 (DIFC) Ltd, TEMA ETFS LLC, NEOS Investment Management LLC, CITADEL ADVISORS LLC, ABC ARBITRAGE SA, Mirae Asset Global Investments Co., Ltd., Tower Research Capital LLC (TRC), and OSAIC HOLDINGS, INC..
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.